Primary and Secondary Prevention of Cancer

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Epidemiology & Public Health".

Deadline for manuscript submissions: 30 June 2024 | Viewed by 147

Special Issue Editor

E-Mail Website
Guest Editor
1. Maccabi Institute for Research & Innovation, Maccabi Healthcare Services, Tel-Aviv, Israel
2. School of Public Health, Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
Interests: preventive medicine; real-world data analysis; pharmacoepidemiology; outcome research; primary care

Special Issue Information

Dear Colleagues,

Cancer, responsible for an estimated 24 million new cases and 10 million deaths each year, stands as the second leading contributor to the global disease burden. Preventive services are an essential component of healthcare, and their underutilization is a persistent concern in developed and developing countries. Several factors, such as cost, time constraints, resource limitations, and patient adherence issues, contribute to the suboptimal results of these critical services. In order to tackle this challenge, it is imperative for researchers and healthcare professionals to remain up to date with the latest advances and draw insights from global healthcare systems in the field of cancer prevention strategies.

Addressing this formidable challenge necessitates that researchers and healthcare professionals stay abreast of the latest advances and glean insights from healthcare systems worldwide, particularly in the realm of prevention strategies. Incorporating cutting-edge tools such as digital health and big data analytics can be instrumental in the early identification of individuals at high risk of cancer.

Moreover, it is paramount to establish effective methods that provide comprehensive explanations regarding the associated risks and benefits to various stakeholders, including patients, decision-makers, and healthcare staff. In this Special Issue, we invite authors to submit their original research articles on the most recent developments in the primary and secondary prevention of cancer. Your contributions will play a pivotal role in enhancing healthcare practices and promoting the widespread adoption of preventive cancer services on a global scale.

Dr. Gabriel Chodick
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • non-communicable diseases
  • preventive medicine
  • primary and secondary prevention
  • real-world data analysis
  • outcome research
  • primary care

Published Papers

This special issue is now open for submission.
Back to TopTop